Back
Corvus Pharmaceuticals, Inc. Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
CRVS
Corvus Pharmaceuticals, Inc.
Last Price:
$8.81
Seasonality Move:
-12.72%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corvus Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.69 | Buy |
| 20-day SMA: | 8.5 | Buy |
| 50-day SMA: | 7.78 | Buy |
| 200-day SMA: | 5.14 | Buy |
| 8-day EMA: | 8.62 | Buy |
| 20-day EMA: | 8.44 | Buy |
| 50-day EMA: | 7.63 | Buy |
| 200-day EMA: | 4.17 | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 57.35 | Buy |
| Chaikin Money Flow: | 784025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.83 - 8.85) | Buy |
| Bollinger Bands (100): | (4.94 - 7.96) | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals, Inc. Stock
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 8.81 while CRVS 8-day simple moving average is 8.69, which is a Buy signal.
-
The stock price of CRVS is 8.81 while Corvus Pharmaceuticals, Inc. 20-day SMA is 8.50, which makes it a Buy.
-
Corvus Pharmaceuticals, Inc. 50-day simple moving average is 7.78 while CRVS share price is 8.81, making it a Buy technically.
-
CRVS stock price is 8.81 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 5.14, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Sell
44
Corvus Pharmaceuticals, Inc. (CRVS)
is a Sell
Is Corvus Pharmaceuticals, Inc. a Buy or a Sell?
-
Corvus Pharmaceuticals, Inc. stock is rated a SellThe current Corvus Pharmaceuticals, Inc. [CRVS] share price is $8.81. The Score for CRVS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Corvus Pharmaceuticals, Inc. Stock Info
Market Cap:
657.9M
Price in USD:
8.81
Share Volume:
1.2M
Corvus Pharmaceuticals, Inc. 52-Week Range
52-Week High:
9.32
52-Week Low:
2.54
Sell
44
Corvus Pharmaceuticals, Inc. (CRVS)
is a Sell
Corvus Pharmaceuticals, Inc. Share Price Forecast
-
What is the Corvus Pharmaceuticals, Inc. stock price today?The Corvus Pharmaceuticals, Inc. stock price is 8.81 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals, Inc. is overvalued.
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 8.81 while CRVS 8-day exponential moving average is 8.62, which is a Buy signal.
-
The stock price of CRVS is 8.81 while Corvus Pharmaceuticals, Inc. 20-day EMA is 8.44, which makes it a Buy.
-
Corvus Pharmaceuticals, Inc. 50-day exponential moving average is 7.63 while CRVS share price is 8.81, making it a Buy technically.
-
CRVS stock price is 8.81 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 4.17, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals, Inc.
Is Corvus Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Corvus Pharmaceuticals, Inc.
Should I short Corvus Pharmaceuticals, Inc. stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Corvus Pharmaceuticals, Inc. is a Buy
-
Corvus Pharmaceuticals, Inc. Relative Strength Index (RSI) is 57.35, which suggest Corvus Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Corvus Pharmaceuticals, Inc. is (7.83 - 8.85), which suggest Corvus Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Corvus Pharmaceuticals, Inc. is (4.94 - 7.96), which suggest Corvus Pharmaceuticals, Inc. is a Buy
* Corvus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.